GlucaGen

Active Ingredient(s): Glucagon
FDA Approved: * June 22, 1998
Pharm Company: * NOVO NORDISK
Category: Hypoglycemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

GlucaGen Overview

1BH0, 1D0R, 1NAU, 2G49, 2L63, 2L64, 2M5P, 2M5Q, 3IOL, 4APD, 4ZGMIdentifiersAliasesGCG, GLP1, GLP2, GRPP, GLP-1, GLP, glucagonExternal IDsOMIM: 138030 HomoloGene: 136497 GeneCards: GCG Gene location (Human)Chr.Chromosome 2 (human)[1]Band2q24.2Start162,142,873 bp[1]End162,152,404 bp[1]RNA expression patternMore reference expression dataGene ontologyMolecular function• protein binding• identical protein binding• receptor binding&#...

Read more GlucaGen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glucagon

Recent GlucaGen Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for GlucaGen: (3 results)

Sorted by National Drug Code

• 0597-0053 Glucagen 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Powder, for Solution by Boehringer Ingelheim Pharmaceuticals, Inc.
• 0597-0260 Glucagen Kit by Boehringer Ingelheim Pharmaceuticals, Inc.
• 55390-004 Glucagen Kit by Bedford Laboratories

Other drugs which contain Glucagon or a similar ingredient: (1 result)

• GLUCAGON